Irvine, CA – Diality has announced the appointment of Peter Donato as Chief Financial Officer. About Diality: Diality Inc. is a medical device company dedicated to developing innovative solutions to enhance the lives of individuals affected by kidney disease. The company has created the Moda-flx Hemodialysis System, a user-friendly, mobile, and connected platform designed to maximize clinical flexibility. This system combines the advanced prescription capabilities typically found in in-center systems with the ease-of-use of next-generation hemodialysis devices. The Moda-flx Hemodialysis System received U.S. Food and Drug Administration (FDA) clearance for use in professional care settings in August 2024. Diality is currently enrolling patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial for its Moda-flx system and is preparing for a limited market release in 2027. The company aims to empower kidney care professionals with variable flow rates, integrated RO water filtration, and an intuitive graphical user interface to customize each hemodialysis experience according to patient needs.

For more information on Diality please visit: https://www.diality.com/

Diality
181 Technology Dr #150
Irvine, CA 92618
Phone: 949-916-5851
LinkedIn Page: https://www.linkedin.com/company/dialityinc/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved